Top analysts rate Philip Morris, Keurig Dr Pepper, Constellation Brands

scanx
Reviewed by
ScanX News Team
Key Highlights

Wall Street analysts have updated views on three high-yield consumer staples stocks. Philip Morris and Constellation Brands raised earnings guidance after beating expectations, though some analysts cut price targets. Keurig Dr Pepper saw price target hikes ahead of its August 6 earnings report. All three stocks offer dividend yields above 3%.

powered bylight_fuzz_icon
46359208

*this image is generated using AI for illustrative purposes only.

Three major consumer staples companies — Philip Morris International Inc., Keurig Dr Pepper Inc., and Constellation Brands Inc. — have drawn fresh attention from top-rated Wall Street analysts, with updates on price targets and ratings reflecting their status as high-yield defensive plays. These firms, all offering dividend yields exceeding 3%, are being closely watched as investors seek stability amid market turbulence. Recent corporate actions include raised earnings guidance from Philip Morris and Constellation Brands, while Keurig Dr Pepper is set to release its second-quarter financial results on August 6.

Philip Morris International Inc. (NYSE: PM)

Philip Morris International continues to attract analyst interest despite slight downward adjustments in price targets by two major banks. The company reported better-than-expected second-quarter financial results on July 22 and subsequently raised its FY26 GAAP EPS guidance, signaling strong operational performance.

Analyst Firm Analyst Name Rating Price Target Change Date Accuracy Rate
Stifel Matthew Smith Buy $200 to $195 April 10, 2026 52%
JP Morgan Jared Dinges Overweight $190 to $185 Nov. 26, 2025 70%

The dividend yield for Philip Morris stands at 3.03%. While both Stifel and JP Morgan maintained positive outlooks with Buy and Overweight ratings respectively, they reduced their price targets. Jared Dinges of JP Morgan, who holds a 70% accuracy rate, cut the target to $185, while Matthew Smith of Stifel lowered his to $195.

Keurig Dr Pepper Inc (NASDAQ: KDP)

Keurig Dr Pepper has seen upward revisions in price targets from two prominent analysts ahead of its upcoming earnings report. The company announced it will release its second-quarter financial results before the opening bell on Thursday, August 6.

Analyst Firm Analyst Name Rating Price Target Change Date Accuracy Rate
UBS Peter Grom Buy $34 to $38 July 16, 2026 60%
Citigroup Filippo Falorni Buy $32 to $37 July 14, 2026 54%

With a dividend yield of 3.05%, Keurig Dr Pepper remains a favorite among income-focused investors. Peter Grom of UBS and Filippo Falorni of Citigroup both maintained Buy ratings while increasing their price targets. Grom raised his target to $38, citing strong fundamentals, while Falorni set his at $37.

Constellation Brands Inc (NYSE: STZ)

Constellation Brands received mixed signals from analysts, with one firm cutting its price target while another maintained a significantly higher outlook. On June 30, the company reported better-than-expected first-quarter financial results and raised its FY27 GAAP EPS guidance.

Analyst Firm Analyst Name Rating Price Target Change Date Accuracy Rate
Barclays Lauren Lieberman Equal-Weight $139 to $132 July 21, 2026 63%
BMO Capital Andrew Strelzik Outperform Maintained at $190 July 2, 2026 59%

Trading with a dividend yield of 3.12%, Constellation Brands shows divergent analyst views. Lauren Lieberman of Barclays reduced the price target to $132 while maintaining an Equal-Weight rating. In contrast, Andrew Strelzik of BMO Capital maintained an Outperform rating with a much higher price target of $190.

What the Numbers Show

The divergence in analyst actions across these three high-yield stocks highlights differing interpretations of near-term valuation versus long-term growth potential. While Philip Morris and Constellation Brands have both raised earnings guidance following strong quarterly reports, analysts like those at Stifel and Barclays have trimmed price targets, possibly reflecting cautious sentiment on multiple expansion. Conversely, the upward revisions for Keurig Dr Pepper by UBS and Citigroup suggest confidence in pre-earnings momentum. Investors should note that despite the yield appeal, price target cuts from high-accuracy analysts such as Jared Dinges (70%) warrant careful consideration of downside risk.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the upcoming Keurig Dr Pepper Q2 earnings report on August 6 influence the broader consumer staples sector's valuation multiples?

What specific operational factors are driving the divergence between Barclays' bearish price target and BMO Capital's bullish outlook for Constellation Brands?

Will the recent price target cuts from high-accuracy analysts like JP Morgan's Jared Dinges signal a broader rotation away from Philip Morris despite its raised EPS guidance?

like19
dislike

Needham raises Philip Morris Intl price target to $215

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Needham analyst Gerald Pascarelli maintained a Buy rating on Philip Morris Intl and raised the price target to $215 from $200, indicating a positive outlook for the stock.

powered bylight_fuzz_icon
46355678

*this image is generated using AI for illustrative purposes only.

Needham analyst Gerald Pascarelli has maintained a Buy rating on Philip Morris Intl and raised the price target to $215 from the previous $200. The revised target suggests increased confidence in the company's valuation and future performance.

Rating and Price Action

The decision to upgrade the price target comes as the firm evaluates Philip Morris Intl's current market position. The stock continues to trade on the NYSE under the ticker PM.

Metric Value
Rating Buy
Previous Price Target $200
New Price Target $215
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Needham's increased confidence in Philip Morris Intl's valuation?

How might Philip Morris Intl's product portfolio evolve to support the new price target?

What are the potential risks to achieving the revised $215 price target?

like18
dislike

More News on Philip Morris International Inc